Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization
- PMID: 32445263
- DOI: 10.1111/jgh.15113
Tri-typing of hepatitis B-related acute-on-chronic liver failure defined by the World Gastroenterology Organization
Abstract
Background and aim: Tri-typing of acute-on-chronic liver failure (ACLF), as proposed by the World Gastroenterology Organization (WGO), has not been validated in patients infected with hepatitis B virus (HBV). We aim to compare the three types of ACLF patients in clinic characteristics.
Methods: Hospitalized ACLF patients with chronic hepatitis B from five hepatology centers were retrospectively selected and grouped according to the WGO classification. For each group, we investigated laboratory tests, precipitating events, organ failure, and clinical outcome.
Results: Compared with type-B (n = 262, compensated cirrhosis) and type-C (n = 129, decompensated cirrhosis) ACLF, type-A patients (n = 195, non-cirrhosis) were associated with a younger age, the highest platelet counts, the highest aminotransferase levels, and the most active HBV replications. HBV reactivation were more predominant in type-A, while bacterial infections in type-B and type-C ACLF cases. Liver failure (97.4%) and coagulation failure (86.7%) were most common in type-A compared with type-B or type-C ACLF patients. Kidney failure was predominantly identified in type-C subjects (41.9%) and was highest (23/38, 60.5%) in grade 1 ACLF patients. Furthermore, type-C ACLF showed the highest 28-day (65.2%) and 90-day (75.3%) mortalities, compared with type-A (48.7% and 54.4%, respectively) and type-B (48.4% and 62.8%, respectively) ACLF cases. Compared with type-A (11.7%) ACLF patients, the increased mortality from 28 to 90 days was higher in type-B (31.6%) and type-C (37.5%).
Conclusion: Tri-typing of HBV-related ACLF in accordance with the WGO definition was able to distinguish clinical characteristics, including precipitating events, organ failure, and short-term prognosis in ACLF patients.
Keywords: Acute-on-chronic liver failure; Chronic hepatitis B virus infection; Liver cirrhosis; Prognosis.
© 2020 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.
References
-
- Jalan R, Williams R. Acute-on-chronic liver failure: pathophysiological basis of therapeutic options. Blood Purif. 2002; 20: 252-261.
-
- Olson JC, Kamath PS. Acute-on-chronic liver failure: concept, natural history, and prognosis. Curr. Opin. Crit. Care 2011; 17: 165-169.
-
- Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2009; 3: 269-282.
-
- Sarin SK, Kedarisetty CK, Abbas Z et al. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int 2014; 8: 453-471.
-
- Moreau R, Jalan R, Gines P et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-1437 1437.e1-9.
MeSH terms
Substances
Grants and funding
- 2019Z003/President Foundation of Nanfang Hospital, Southern Medical University
- LC2019ZD006/Clinical Research Startup Program of Southern Medical University by High-level University Construction Funding of Guangdong Provincial Department of Education
- 2018CR037/Clinical Research Program of Nanfang Hospital, Southern Medical University
- 2014B020228003/Department of Science and Technology of Guangdong Province
- 2015B020226004/Department of Science and Technology of Guangdong Province
- 201508020262/Key Scientific and Technological Program of Guangzhou City
- 2017YFC0908100/National Key Research and Development Program of China
- 81270533/National Natural Science Foundation of China
- 81470038/National Natural Science Foundation of China
- 2018ZX10723203/National Science and Technology Major Project
LinkOut - more resources
Full Text Sources
